24
Participants
Start Date
December 1, 2017
Primary Completion Date
December 1, 2018
Study Completion Date
July 1, 2019
Aminolevulinic Acid Topical 20% Topical Solution
PDT involves the topical application of aminolevulinic acid (ALA), or one of its derivatives, as a photosensitizing agent. Subjects will receive ALA in all treatment arms (A, B, and C).
BLU-U blue light phototherapy illuminator
Depending on the treatment arm, subjects will either receive BLU-U exposure or not. Treatment arms A and B have BLU-U exposure and treatment arm C does not.
UCSF Dermatology, San Francisco
University of California, San Francisco
OTHER